日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

PUNCH CD3-OLS: A Phase 3 Prospective Observational Cohort Study to Evaluate the Safety and Efficacy of Fecal Microbiota, Live-jslm (REBYOTA) in Adults With Recurrent Clostridioides difficile Infection

PUNCH CD3-OLS：一项评估粪便微生物群、活体jslm（REBYOTA）治疗复发性艰难梭菌感染成人患者的安全性和有效性的3期前瞻性观察队列研究

期刊:Clinical Infectious Diseases
影响因子:7.3
doi:10.1093/cid/ciae437
Feuerstadt, Paul; Chopra, Teena; Knapple, Whitfield; Van Hise, Nicholas W; Dubberke, Erik R; Baggott, Brian; Guthmueller, Beth; Bancke, Lindy; Gamborg, Michael; Steiner, Theodore S; Van Handel, Daniel; Khanna, Sahil
炎症/感染
CD3
微生物学
发表日期：2025
文献求助 收藏

Safety and Efficacy of Fecal Microbiota, Live-jslm (REBYOTA®), for the Prevention of Recurrent Clostridioides difficile Infection in Participants With Inflammatory Bowel Disease in PUNCH CD3-OLS

在 PUNCH CD3-OLS 研究中，评估粪便微生物群 Live-jslm (REBYOTA®) 预防炎症性肠病患者复发性艰难梭菌感染的安全性和有效性

期刊:Inflammatory Bowel Diseases
影响因子:4.3
doi:10.1093/ibd/izae291
Allegretti, Jessica R; Feuerstadt, Paul; Knapple, Whitfield L; Orenstein, Robert; Pinton, Philippe; Sheh, Alexander; Khanna, Sahil
炎症/感染
CD3
炎症
微生物学
发表日期：2025
文献求助 收藏

Safety and effectiveness of fecal microbiota, live-jslm (REBYOTA(®)) administered by colonoscopy for prevention of recurrent Clostridioides difficile infection: 8-week results from CDI-SCOPE, a single-arm, phase IIIb trial

通过结肠镜给予粪便微生物活体jslm（REBYOTA®）预防复发性艰难梭菌感染的安全性和有效性：一项单臂IIIb期试验CDI-SCOPE的8周结果

期刊:
影响因子:
doi:10.1177/17562848251339697
Khanna, Sahil; Yoho, David; Van Handel, Daniel; Clark, Brian J; Awad, Tahany; Guthmueller, Beth; Armandi, Daniel; Knapple, Whitfield; Safdar, Nasia; Baggott, Brian; Simon, Karen; Feuerstadt, Paul
炎症/感染
微生物学
发表日期：2025
文献求助 收藏

Prevention of recurrent Clostridioides difficile infection by fecal microbiota, live-jslm (REBYOTA(®)) administered via colonoscopy: 6-month data from the single-arm phase IIIb CDI-SCOPE trial

通过结肠镜给予粪便微生物活菌（REBYOTA®）预防复发性艰难梭菌感染：单臂 IIIb 期 CDI-SCOPE 试验的 6 个月数据

期刊:
影响因子:
doi:10.1177/17562848251396744
Khanna, Sahil; Yoho, David; Van Handel, Daniel; Clark, Brian J; Awad, Tahany; Guthmueller, Beth; Armandi, Daniel; Knapple, Whitfield; Safdar, Nasia; Baggott, Brian; Simon, Karen; Feuerstadt, Paul
炎症/感染
微生物学
发表日期：2025
文献求助 收藏

Retrospective subgroup analysis of fecal microbiota, live-jslm (REBYOTA(®)) administered by colonoscopy under enforcement discretion for the prevention of recurrent Clostridioides difficile infection

对通过结肠镜检查酌情施用的粪便微生物活菌制剂（REBYOTA®）进行回顾性亚组分析，以预防复发性艰难梭菌感染。

期刊:
影响因子:
doi:10.1177/17562848241239547
Knapple, Whitfield L; Yoho, David S; Sheh, Alexander; Thul, Joan; Feuerstadt, Paul
炎症/感染
微生物学
发表日期：2024
文献求助 收藏

Retrospective Analysis of the Safety and Efficacy of Fecal Microbiota, Live-jslm (REBYOTA(TM)) Administered Under Enforcement Discretion to Patients With Clostridioides difficile Infection

对在执法酌情权下使用粪便微生物活体jslm（REBYOTA™）治疗艰难梭菌感染患者的安全性和有效性进行回顾性分析

期刊:Open Forum Infectious Diseases
影响因子:3.8
doi:10.1093/ofid/ofad171
Feuerstadt, Paul; Harvey, Adam; Yoho, David S; Garcia-Diaz, Julia B; Knapple, Whitfield L; Bancke, Lindy
炎症/感染
微生物学
发表日期：2023
文献求助 收藏